Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke

Circ Res. 2013 Sep 27;113(8):1013-22. doi: 10.1161/CIRCRESAHA.113.301207. Epub 2013 Jun 18.

Abstract

Rationale: Blood-brain-barrier (BBB) breakdown and cerebral edema result from postischemic inflammation and contribute to mortality and morbidity after ischemic stroke. A functional role for the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in the regulation of reperfusion injury has not yet been demonstrated.

Objective: We sought to identify and characterize the relevance of CEACAM1-expressing inflammatory cells in BBB breakdown and outcome after ischemic stroke in Ceacam1(-/-) and wild-type mice.

Methods and results: Focal ischemia was induced by temporary occlusion of the middle cerebral artery with a microfilament. Using MRI and Evans blue permeability assays, we observed increased stroke volumes, BBB breakdown and edema formation, reduction of cerebral perfusion, and brain atrophy in Ceacam1(-/-) mice. This translated into poor performance in neurological scoring and high poststroke-associated mortality. Elevated neutrophil influx, hyperproduction, and release of neutrophil-related matrix metalloproteinase-9 in Ceacam1(-/-) mice were confirmed by immune fluorescence, flow cytometry, zymography, and stimulation of neutrophils. Importantly, neutralization of matrix metalloproteinase-9 activity in Ceacam1(-/-) mice was sufficient to alleviate stroke sizes and improve survival to the level of CEACAM1-competent animals. Immune histochemistry of murine and human poststroke autoptic brains congruently identified abundance of CEACAM1(+)matrix metalloproteinase-9(+) neutrophils in the ischemic hemispheres.

Conclusions: CEACAM1 controls matrix metalloproteinase-9 secretion by neutrophils in postischemic inflammation at the BBB after stroke. We propose CEACAM1 as an important inhibitory regulator of neutrophil-mediated tissue damage and BBB breakdown in focal cerebral ischemia.

Keywords: animal model of human disease remodeling; inflammation; ischemic stroke; neutrophils; vascular system injuries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / metabolism*
  • Atrophy
  • Behavior, Animal
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / enzymology*
  • Blood-Brain Barrier / immunology
  • Blood-Brain Barrier / pathology
  • Brain Edema / enzymology
  • Brain Edema / immunology
  • Brain Edema / pathology
  • Capillary Permeability
  • Carcinoembryonic Antigen / genetics
  • Carcinoembryonic Antigen / metabolism*
  • Cell Adhesion Molecules / metabolism*
  • Disease Models, Animal
  • Flow Cytometry
  • Heterocyclic Compounds, 1-Ring / pharmacology
  • Humans
  • Infarction, Middle Cerebral Artery / enzymology*
  • Infarction, Middle Cerebral Artery / genetics
  • Infarction, Middle Cerebral Artery / immunology
  • Infarction, Middle Cerebral Artery / pathology
  • Infarction, Middle Cerebral Artery / physiopathology
  • Infarction, Middle Cerebral Artery / prevention & control
  • Inflammation Mediators / metabolism*
  • Magnetic Resonance Imaging
  • Male
  • Matrix Metalloproteinase 9 / metabolism*
  • Matrix Metalloproteinase Inhibitors / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microscopy, Fluorescence
  • Motor Activity
  • Neurologic Examination
  • Neutrophil Activation
  • Neutrophil Infiltration
  • Neutrophils / drug effects
  • Neutrophils / enzymology*
  • Neutrophils / immunology
  • Neutrophils / pathology
  • Sulfones / pharmacology
  • Time Factors

Substances

  • Antigens, CD
  • CD66 antigens
  • Carcinoembryonic Antigen
  • Ceacam1 protein, mouse
  • Cell Adhesion Molecules
  • Heterocyclic Compounds, 1-Ring
  • Inflammation Mediators
  • Matrix Metalloproteinase Inhibitors
  • SB 3CT compound
  • Sulfones
  • MMP9 protein, human
  • Matrix Metalloproteinase 9
  • Mmp9 protein, mouse